Zhiwei Song obtained his PhD in Biochemistry from the University of Michigan where he studied plant lectins and protein glycosylation in cancer cells. Thereafter, he completed his postdoctoral research at the Massachusetts Institute of Technology (MIT) where he studied genetic control of apoptosis. Song is currently a Senior Principal Scientist at the Bioprocessing Technology Institute at A*STAR. His research focuses on protein glycosylation, glycoengineering of CHO cells, and the production and characterization of recombinant biologics.
